Cost-effectiveness of uterine balloon tamponade devices in managing atonic post-partum hemorrhage at public health facilities in India

PLoS One. 2021 Aug 18;16(8):e0256271. doi: 10.1371/journal.pone.0256271. eCollection 2021.

Abstract

Objective: Post-partum hemorrhage (PPH) is the leading direct cause of maternal mortality in India. Uterine balloon tamponade (UBT) is recommended for atonic PPH cases not responding to uterotonics. This study assessed cost-effectiveness of three UBT devices used in Indian public health settings.

Methods: A decision tree model was built to assess cost-effectiveness of Bakri-UBT and low-cost ESM-UBT alternatives as compared to the recommended standard of care i.e. condom-UBT intervention. A hypothetical annual cohort of women eligible for UBT intervention after experiencing atonic PPH in Indian public health facilities were evaluated for associated costs and outcomes over life-time horizon using a disaggregated societal perspective. Costs by undertaking primary costing and clinical parameters from published literature were used. Incremental cost per Disability Adjusted Life Years (DALY) averted, number of surgeries and maternal deaths with the interventions were estimated. An India specific willingness to pay threshold of INR 24,211 (USD 375) was used to evaluate cost-effectiveness. Detailed sensitivity analysis and expected value of information analysis was undertaken.

Results: ESM-UBT at base-case Incremental Cost-Effectiveness Ratio (ICER) of INR -2,412 (USD 37) per DALY averted is a cost-saving intervention i.e. is less expensive and more effective as compared to condom-UBT. Probabilistic sensitivity analysis however shows an error probability of 0.36, indicating a degree of uncertainty around model results. Bakri-UBT at an ICER value of INR -126,219 (USD -1,957) per DALY averted incurs higher incremental societal costs and is less effective as compared to condom-UBT. Hence, Bakri-UBT is not cost-effective.

Conclusion: For atonic PPH management in India, condom-UBT offers better value as compared to Bakri-UBT. Given the limited clinical effectiveness evidence and uncertainty in sensitivity analysis, cost-saving result for ESM-UBT must be considered with caution. Future research may focus on generating high quality comparative clinical evidence for UBT devices to facilitate policy decision making.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cost-Benefit Analysis*
  • Decision Trees
  • Disability-Adjusted Life Years / trends
  • Female
  • Health Facilities / economics*
  • Humans
  • India
  • Maternal Mortality / trends
  • Parturition / physiology
  • Postpartum Hemorrhage / economics
  • Postpartum Hemorrhage / mortality
  • Postpartum Hemorrhage / pathology
  • Postpartum Hemorrhage / therapy*
  • Pregnancy
  • Uterine Balloon Tamponade / economics*
  • Uterine Balloon Tamponade / methods

Grants and funding

The study was funded by the Department of Health Research (DHR), Government of India under the grant no. T. 11011/02/2017 - HR/3100291. The funds were received in the name of the Director, NIRRH that was further allocated to the principal investigator BNJ. URL - https://htain.icmr.org.in/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.